Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Extracorporeal lithotripsy in children].

J Moreno Aranda1, U Cedillo López, J L López Pellerano

  • 1Servicio de Urología, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, IMSS.

Gaceta Medica De Mexico
|May 1, 1992
PubMed
Summary

Extracorporeal shock wave lithotripsy effectively treated pediatric kidney stones in 14 children, achieving a 71.4% stone-free rate within three months. Ultrasound guidance minimized radiation exposure during these procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Assessment of effectiveness of and tolerance to oxybutynin in the treatment of unstable bladder in women].

Ginecologia y obstetricia de Mexico·2000
See all related articles

Area of Science:

  • Pediatric Urology
  • Nephrology
  • Medical Technology

Context:

  • Pediatric kidney stones (renal and ureteral calculi) pose a significant health challenge.
  • Traditional treatment methods may involve invasive procedures or significant radiation exposure.
  • Extracorporeal shock wave lithotripsy (ESWL) offers a non-invasive therapeutic option.

Purpose:

  • To evaluate the efficacy and safety of Piezolith 2300 extracorporeal shock wave lithotripsy for treating pediatric renal and ureteral calculi.
  • To assess stone-free rates, complication incidence, and treatment parameters in a pediatric cohort.
  • To determine the feasibility of ESWL in children with minimal need for anesthesia or sedation.

Summary:

  • Fourteen pediatric patients with renal and ureteral calculi underwent treatment with Piezolith 2300 ESWL.

Related Experiment Videos

  • The average patient age was 9.7 years, with calculi primarily located in the renal pelvis.
  • A stone-free rate of 71.4% was achieved at 3 months, with hematuria and mild hyperthermia/renal colic as main side effects.
  • Ultrasound guidance was utilized for stone localization, and only 16.6% of patients required sedation.

    • Impact:

    • Demonstrates ESWL as a viable and effective treatment for pediatric kidney stones, comparable to adult outcomes.
    • Highlights the benefit of ultrasound guidance in reducing radiation exposure for pediatric patients.
    • Suggests that Piezolith 2300 ESWL can be performed with minimal anesthesia, improving patient tolerance and safety.